Cáncer microcítico de pulmón
- Navarro Expósito, Fátima
- López González, José Luis
- Molina Villaverde, Raquel
- Álvarez de Mon Soto, Melchor
ISSN: 0304-5412
Year of publication: 2013
Issue Title: Enfermedades oncológicas (I): cáncer de pulmón y torácico, cabeza y cuello, sistema nervioso central
Series: 11
Issue: 24
Pages: 1441-1446
Type: Article
More publications in: Medicine: Programa de Formación Médica Continuada Acreditado
Abstract
Small cell lung cancer is a rapid growing neoplasm with good initial response to chemotherapy treatment. However, the response is generally short-lived. In limited stage, the treatment of choice is a combination of cisplatin and etoposide, together with radiotherapy concomitantly. Response rate is high and a significant percentage of long survivals can be achieved. However, in disseminated stage, and despite the chemotherapy, global survival is very short, the patients hardly surviving more than 2 years. In spite of the development of many new drugs in Oncology, few of them have been promising in this cancer.